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S U M M A R Y
Tuberculosis (TB)-related stigma is an important social determinant of health. Research generally
highlights how stigma can have a considerable impact on individuals and communities, including delays
in seeking health care and adherence to treatment. There is scant research into the assessment of TB-
related stigma in low incidence countries. This study aimed to systematically map out the research into
stigma. A particular emphasis was placed on the methods employed to measure stigma, the conceptual
frameworks used to understand stigma, and whether structural factors were theorized. Twenty-two
studies were identiﬁed; the majority adopted a qualitative approach and aimed to assess knowledge,
attitudes, and beliefs about TB. Few studies included stigma as a substantive topic. Only one study aimed
to reduce stigma. A number of studies suggested that TB control measures and representations of
migrants in the media reporting of TB were implicated in the production of stigma. The paucity of
conceptual models and theories about how the social and structural determinants intersect with stigma
was apparent. Future interventions to reduce stigma, and measurements of effectiveness, would beneﬁt
from a stronger theoretical underpinning in relation to TB stigma and the intersection between the social
and structural determinants of health.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
1.1. TB in low incidence countries
Tuberculosis (TB) is a major global public health problem
affecting lower and middle income countries.1,2 TB continues to
present a signiﬁcant challenge in 33 low incidence countries
(deﬁned as 100 cases per million), which would include most of
Western Europe, the USA, Canada, Australia, and New Zealand.
Cases of TB are over-represented in socially and economically
marginalized populations in low incidence, high income countries
and, in particular, in migrant communities.1 More than 50% of TB
cases in low incidence countries occur amongst people born
outside of those countries; in some cases this ﬁgure increases to
90%.1 Migration from countries of high to low disease burden is
unlikely to decrease.* Corresponding author. Tel.: +44 0 20 7040 5843.
E-mail address: gill.craig.1@city.ac.uk (G.M. Craig).
http://dx.doi.org/10.1016/j.ijid.2016.10.011
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).In the UK in 2013, 70% of TB cases came from the 40% most
economically deprived areas and 44% of TB cases did not have
employment.3 In low incidence countries, TB is concentrated in
groups often deﬁned as hard-to-reach, or underserved, and is
characterized by complex health and social risks,4 for example
homelessness, imprisonment, high rates of alcohol and substance
misuse, HIV, a recent history of migration from countries with a
high disease burden, and lack of entitlement to welfare. All of these
factors can impact on access to health care and treatment
outcomes and present particular challenges for services that
may lack the necessary resources to outreach a service to
vulnerable communities.
In response to these unique challenges, in 2014 the World
Health Organization (WHO), in collaboration with the European
Respiratory Society (ERS),5 developed a framework of eight priority
actions for the elimination of TB in countrieswith low incidence (or
approaching low incidence): ensuring political commitment,
addressing the needs of vulnerable and hard-to-reach groups
andmigrants (which includes actions to mitigate stigma), targeted
screening for both active and latent disease in high-risk groups,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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efforts, care and control, action on drug-resistant TB, and
investment in research.5 The framework clearly outlines the
challenge of decreasing TB incidence from>1000 cases per million
population to <100 cases per million by 2035. Out of the
33 countries (see Table 1), all but six have experienced an average
rate of decline of approximately 3% over a 12-year period. However
future projections suggest that no low incidence country will
manage to eliminate TB by 2035 and only one country would
manage to eliminate TB by 2050. The authors concluded that: ‘‘the
task of reaching TB elimination in the coming decades may thus
seem daunting, even in countries with the lowest incidence in the
world’’1 (page 931).
In the last decade, we havewitnessed a sea change in policy and
rhetoric underpinning TB care from one focused on a curative
model to one that, additionally, aims to tackle the social
determinants of disease that render people vulnerable to TB and
impact on their ability to sustain a course of treatment.6,7 The
social determinants of health (SDH) include the range of social,
political, economic, and environmental factors that determine the
health status of populations and hence risk of TB and treatment
outcomes. Despite the evidence that wealth inequalities are an
important predictor of TB rates in low incidence countries,8,9 some
argue that the social determinants of TB are overlooked given the
dominance of biomedical approaches,10 which still emphasize case
detection, case management, and screening and surveillance,
particularly ofmigrant communities in TB control efforts. TB policy
may therefore reﬂect concerns about border control.11,12 The
situation in low incidence countries, therefore, is symptomatic of a
global response to TB focused on technical and biomedical
solutions and the general failure of global TB control efforts to
address the underlying causes of TB.
1.2. Stigma as a social determinant of health
Stigma is a social determinant of health,13 found to be a major
barrier to accessing health care (hence resulting in diagnostic
delay) and the ability to manage illness and complete treat-
ment.14–16 Conceptualizations of stigma are most often borrowed
fromGoffman,17 who deﬁned stigma as ‘‘an attribute that is deeply
discrediting’’ (page 3), which ‘spoils’ a person’s social identity or
sense of self. Goffman distinguished between people who are
‘discredited’, whose stigma is visibly apparent or ‘known about’,
and the ‘discreditable’, those whose stigma is only occasionally
apparent as in the case of epilepsy.18 Scambler differentiated
between ‘felt’ stigma, or the fear of discrimination perceived by
individuals, and ‘enacted’ stigma, an overt act of discrimination.18
He posited that felt stigma was ultimately more socially and
emotionally disruptive than enacted stigma because of the
psychological work (covering) an individual has to do to keep
the stigma hidden from others; for example: secrecy, avoidance,
and withdrawal from relationships,19,20 resulting in loneliness and
social isolation, or in some cases, engaging in risky behavior.1,21
Goffman used the term ‘courtesy stigma’ to describe the way
stigma extends to others by virtue of their association with the
stigmatized individual.
Others have differentiated between (1) internalized22 or self-
stigma23 (believing negative public stereotypes and translating
those negative perceptions to oneself), as exempliﬁed in people
with HIV,24 mental illness,25,26 and other concealable illnesses, (2)
anticipated stigma27 (fear of experiencing the negative effects of
stigmatization, akin to felt stigma), and (3) experienced stigma22,27
(discrimination, akin to enacted stigma).
Courtwright and Turner suggest stigmatization is different from
discrimination, as the former hasmore to dowith shame, while the
latter involves exclusion.28 Here stigmatization is seen as ‘‘acomplex process involving institutions, communities, and inter-
and intrapersonal attitudes’’ (page 34). However, Deacon argues
that stigma and discrimination, although related, are distinct
entities, and calls for greater clarity on the relationship between
the two, suggesting that stigma suffers from ‘‘conceptual inﬂation’’
and ‘‘lack of analytical clarity’’ (page 419).16
These dimensions of stigma are not exhaustive or mutually
exclusive when it comes to understanding stigma in relation to a
social disease such as TB. Rather, they are inextricably linked to an
individual’s social positioning.29–31 The prevalence of double or
multiple stigmas is recorded among individuals affected by
overlapping illnesses and social statuses. For example, multiple
stigmas are documented along the lines of mental illness and
race,32 mental illness and old age,30 and mental illness and
cancer.33 Multiple stigmas are also identiﬁed among HIV-positive
persons in the context of their minority ethnic status, race, sexual
orientation,31,34 and/or gender.35 Studies with HIV patients show
thatmultiple stigmas result in a greater social burden of illness, for
which reason they may delay accessing medical attention and
suffer worse adherence to prescribed treatments.31,32,34,35 In high
HIV prevalence settings, TB is labelled as a marker for HIV, leading
to distinct forms of double stigma that render stigmas associated
withHIV to be transferred to those livingwith TB, and reinforce the
stigmatization of HIV.29
Contemporary scholars such as Link and Phelan36 and Parker
and Aggleton,37 suggest that the negative labelling of particular
traits is socially created and used as a tool to assert dominance over
people who are alreadymarginalized within society on the basis of
extant social inequalities (location), such as those related to race,
class, religion, or gender. These later conceptualizations of stigma
resonate with the social determinants of TB,38,39 and allow for
stigma to be conceived of as a socially constructed phenomenon
rather than an individualistic issue.
Technologies used to control TB, diagnostics, drugs, and
guidelines have also been implicated in this social construction
of stigma and can further reinforce stigma and stigmatizing
practices. Innovations and technologies intersect with the setting
they are introduced into and at times have unintended con-
sequences; for instance HIV rapid tests that, due to their rapidity
and ease of use, allow some private doctors to test for HIV without
the patient’s knowledge, further reinforcing the existing stigma
that prevents patients agreeing to HIV testing.40 Similarly, patient
treatment cards that identify patients as coinfected with HIV and
TB through their colour,41 or directly observed therapy (DOTS)
treatment schedules that expect patients to attend a TB clinic in
their community daily, can reinforce existing stigma. This suggests
that TB control policies and research need to critically examine
how to address the social determinants of TB, including the aspects
of TB control that allow, perpetuate, or generate stigmatizing
practices.
These different deﬁnitions and understandings are important
because, as Deacon16 (page 419) states: ‘‘Theories provide
frameworks or models within which researchers can develop
better research and intervention strategies’’. For if we cannot
deﬁne stigma and understand how it operates, how can we
measure stigma and devise strategies for reducing it?
Generally, more research into interventions for reducing HIV
stigma has been conducted and reviewed in systematic and global
reviews42–44 than research into TB stigma reduction strategies, for
which the ﬁrst systematic review in the ﬁeld is currently
underway.45 Research into TB-related stigma has predominantly
taken place in high incidence countries and, arguably, the evidence
base is lesswell developed in lowburden countries. For example, in
one qualitative review of the stigma of TB, only four out of
30 studies were from the USA and conducted before 2006; the
remainder came from high incidence countries.19 Another review
Table 1
TB in 33 low incidence countries referenced in the
framework1
Estimated rate per 100,000 population (2014)
High income countriesa TB rateb
Australia 6.4
Austria 7.8
Bahamas 12
Belgium 9
Canada 5.2
Cyprus 5.3
Czech Republic 4.6
Denmark 7.1
Finland 5.6
France 8.7
Germany 6.2
Greece 4.8
Iceland 3.3
Ireland 7.4
Israel 5.8
Italy 6
Luxembourg 12
Malta 12
Netherlands 5.8
New Zealand 7.4
Norway 8.1
Puerto Rico 1.4
Slovak Republic 6.7
Slovenia 7.7
Sweden 7.5
Switzerland 6.3
United Arab Emirates 1.6
USA 3.1
Upper middle income countriesa
Costa Rica 11
Cuba 9.4
Jamaica 4.7
Jordan 5.5
Lower middle income countriesa
West Bank and Gaza Strip 5.8
a World Bank list of economies (July 2016).
b Global Tuberculosis Report 2015. Key TB indicators for
individual countries, and territories, WHO regions and the
world. http://www.who.int/tb/publications/global_report/
gtbr15_annex04.pdf?ua=1.
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Asia and the Paciﬁc Islands (33%), or were multiregional (17%) or
from Africa and the Middle East (28%). North America comprised
9%, with Latin/South America 8% and Europe/Russia 8%.28
However, results were synthesized and not differentiated accord-
ing to context or TB disease burden. Chang andCataldo conducted a
systematic review of global cultural variations in knowledge,
attitudes, and health responses to TB stigma, where out of
83 studies, two were from the UK and eight were from the USA.46
Given stigma is increasingly associatedwith health inequalities,
the aim of this review is to contribute to debates about stigma as a
social determinant of health and, in particular, ways in which
stigma is deﬁned and measured, including any tools and
interventions that are effective in reducing stigma.47 It was with
this in mind that a systematic mapping review of research into TB-
related stigma in low incidence countries was conducted to map
out recent research (the last 10 years), the main characteristics,
conceptual models used and to identify any gaps.
2. Methods
A systematicmapping review of the literaturewas conducted to
identify research into TB stigma and associated interventions to
mitigate the impact of TB stigma.48 Mapping reviews aim to map
out and categorize research on a given topic with a view to
identifying evidence gaps and commission further reviews or
research as required.Mapping reviews do not appraise research for
quality, but rather describe and categorize the existing evidence
base.48 In this review, the aim was to explore: (a) whether stigma
was the main focus of the research, (b) the theoretical under-
pinnings of the concept of stigma used in studies and whether this
was based on individual-level explanations or factored in broader
social determinants, as well as how stigma was deﬁned,
operationalized, and measured.
2.1. Inclusion and exclusion criteria
All articles from a low incidence country, deﬁned as100 cases
per million, were included. However, because low incidence has
also been deﬁned as20 cases per 100 000, and in order to enhance
the scope of the review, countries that were deﬁned as low
incidence using the broader deﬁnition were included to incorpo-
rate countries approaching low incidence, in line with the action
framework. Table 1 highlights all the countries as a result of the
more inclusive deﬁnition. Studies were also included if they
reported on primary research, including both qualitative and
quantitative studies or mixed methods; the focus was active or
latent TB infection (LTBI); interventions aimed to reduce stigma;
they aimed to explore or measure stigma including knowledge,
attitudes, beliefs, or experiences about TB, or health-seeking
practices or adherence. Only studies published in peer-reviewed
journals were included. The search was limited to articles
published between January 1, 2006 and August 1, 2016.
Articles were excluded if they were not written in the English
language, published in the grey literature, an opinion piece, a
conference abstract or dissertation, or a systematic review.
2.2. Keyword strategy
A keyword strategy was developed based on previous work
involving the lead author and an information scientist.49 Search
terms included medical subject heading (MeSH) or other
associated terms for TB and stigma. Two other researchers
reviewed the strategy (see Appendix A for an example). Additional
articles were obtained through ancestral searches.2.3. Databases
The following databases were searched: Centre for Reviews and
Dissemination, CINAHL, Cochrane Central Register of Controlled
Trials, Cochrane Database of Systematic Reviews, MEDLINE,
PsychInfo, Embase, ERIC, SocINDEX, Social Policy & Practice, Global
Health.
2.4. Data extraction
The review and data extraction were informed by a critical
health psychology perspective (CHPP), which understands health
and illness behaviour within social, political, and cultural contexts
that not only inﬂuence health and illness, but systems of health
and social care.50,51 This approach also takes cognizance of the
SDH. The resulting framework was developed and studies coded
according to the year, country, sample characteristics, methods,
whether a deﬁnition of stigma was provided and the conceptual
framework used,whether it was an intervention study, how stigma
was measured, whether the focus included other diseases/co-
morbidities, e.g., HIV–TB stigma, and outcomes. The studies were
further coded according to the thematic content. All abstracts were
searched and where it was unclear whether the article should be
included, the full article was read. All articles were reviewed
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researcher reviewed all articles.
3. Results
The abstracts of 204 citations were identiﬁed from the search
and an additional 14 from other sources (including seven articles
obtained when the search was re-run to include the names of
additional low incidence countries in line with the inclusive
deﬁnition). Fifty-three duplicates were removed leaving
165 abstracts, and 134 of these were excluded. Of the remaining
31 articles, nine were excluded at full review, leaving 22 studies in
total. Figure 1 provides the reasons for the exclusions.
3.1. Which low incidence country has conducted research into TBwith
relevance to stigma?
Twenty-two studies were included in the review. The majority
of studies (n = 10) were conducted in Canada/USA, followed by the
UK (n = 7), Europe (n = 2), and Australia/New Zealand (n = 3). There
was only one intervention study (health education), which was
conducted in Australia52 although TB was not the main focus and
neither was stigma. There were no studies from lower/middle
income countries represented in this review. Table 2 characterizes
the studies in more detail.
3.2. What type of community was the focus of the research?
Most of the research studies focused on migrant communities,53
including communities from broadly Spanish-speaking South
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Figure 1. FlowAmerican and Caribbean countries,54–57 Sub-Saharan African
refugees,52 migrants or refugees from Somalia or Ethiopia,58–60
Chinese migrants,61 African communities/migrants,62 homeless
populations,57,63,64 migrant and refugee learners,65 and a mixed
population of migrants;66,67 one study was performed in an
indigenous community – the Inuit.68 Only one study surveyed the
views of the general population in the USA.69 Three textual studies
aimed to analyse how migrants were represented in the media in
relation to reports about TB.70,71,81 The focus on different migrant
communities reﬂects patterns of migration in different countries.
Three studies involved community leaders and their views on how
TB and stigmawere perceived within their own communities.54,58,67
3.3. What research methods were used?
The majority of studies (18/22) could best be described as
qualitative, involving interviews and/or focus groups; three of
these 18 studies adopted a textual analysis of print media and ﬁve
adopted an ethnographic approach. Two out of the total 22 studies
involved population-based surveys and there was one mixed
methods study involving a patient survey and focus group. Two
studies involved a comparator group. Coreil et al. compared the
views of Haitianmigrants living in Floridawith Haitians residing in
Haiti.55 Sheik and MacIntyre compared 34 Sub-Saharan African
refugee parents with 12 non-African refugee parents.52
3.4. Was stigma the main focus for the research?
Few studies set out to research TB-related stigma as the main
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Table 2
Included studies
No. Country Authors Methods Participants and other
details
Conceptual framework Selected ﬁndings in relation to
stigma
1 USA/Canada Colson et al., 2014
[54]
Population-based cross-
sectional survey;
structured interviews
administered face-to-face
1475 participants; born
outside USA/Canada
K-A-B Improved health education for
people born outside receiving
country.
Measures to reduce stigma
needed
2 Australia Sheikh and
MacIntyre, 2009
[53]
Intervention study;
structured questionnaire
developed in focus groups
administered face-to-face
34 Sub-Saharan African
refugees and 12 non-
African refugee parents
K-A-B Targeted promotion to refugee
parents is effective in changing
K-A-B about infectious diseases
3 USA Lurie et al., 2012
[55]
Qualitative research 5 bilingual focus groups
including Mexican, Puerto
Rican, Venezuelan,
Ecuadoran, Haitian
American, and indigenous
persons from Latin
America; interviews with
agency leaders and staff
K-A-B Local agencies can serve as
informed liaisons to improve the
health of newly arrived
immigrants
Stigmatized through public
health emphasis on elevated risk
4 USA Wieland et al.,
201265
Community-based
participatory research
10 focus groups;
83 people in total;
immigrant and refugee
learners and staff in an
adult education centre
Health belief model Perception of TB included
secrecy, shame, fear and
isolation
Adult education centres with
large immigrant and refugee
populations are good venues for
TB prevention
5 Australia Horner, 2016 [71] Qualitative research;
critical textual analysis;
interviews; analysis of
print media
19 migrants with TB in
Canada, HCP
Discourse theory Need to prioritize settlement
support and health care rather
than disease through migrant
screening, which reinforces
stigma
6 Canada Gao et al., 2015 [62] Qualitative research;
mixed methods cross-
sectional patient survey,
focus group
912 survey respondents
and 2 focus groups;
Chinese immigrants
K-A-B Need to raise awareness of LTBI
and reduce LTBI-related stigma
Cost of treatment a signiﬁcant
barrier
7 Canada Reitmanova and
Gustafson, 2012
[82]
Qualitative research;
textual analysis of print
media
273 news articles,
editorial and letters
analysis; of how are
migrants represented in
media
Discourse theory TB control policies focus on
screening and surveillance
Media racializes and represents
migrants as a health threat
8 New Zealand Lawrence et al.,
2008 [72]
Qualitative research,
newspaper reports as a
case study; textual
analysis
120 media
representations of TB
Discourse theory Media fails to report on links
between the SDH and TB
Migrants stigmatized
Attention to the cultural and
political context needed when
reporting TB
9 USA/Haiti Coreil et al., 2010
[56]
Mixed method, cultural
epidemiology and
ethnography using EMIC
182 in-depth interviews
and 12 focus group
Haitians living in South
Florida; Haitians residing
in Leogane Commune,
Haiti
Structural forces in the
production of TB-
related stigma
perceived and
anticipated stigma
Discussions of ﬁndings focused
on the social production of
perceived and anticipated
stigma as inﬂuenced by politics,
economics, institutional polices
and health service delivery
structures
Findings demonstrate value of
transnational framework
10 USA Joseph et al., 2008
[57]
Ethnographic research 50 interviews with
Mexican-born persons
living in Atlanta/Denver in
the USA
Socio-cultural aspects
of TB reﬂected in
stigma scale
Concern about stigma varied,
depending on TB status
Anticipated stigma by thosewith
no history of TB was greater than
the actual stigma reported by
people who had TB disease
11 UK Nnoaham et al.,
2006 [63]
Qualitative interview
study
16 people self-identiﬁed
as African living in the UK
attending a clinic for TB
treatment, London, UK
Enacted or felt stigma
using Kleinman’s
explanatory model of
illness
Despite reports of felt stigma,
denial reduced with good coping
strategies
Reports of good adherence
suggest stigma can be mitigated
12 USA West et al., 2008
[58]
Qualitative research, focus
groups
11 focus groups;
52 participants; Spanish-
speaking immigrants,
homeless shelter
residents, and persons
attending a drug/alcohol
rehabilitation centre
K-A-B Participants projecting disease
onto other social groups
perceived as less desirable is also
evidence of stigma
13 UK Gerrish et al., 2013
[60]
A focused ethnography
with individual
interviews
14 Somali refugees who
had received treatment
for TB in the UK; 18 health
care practitioners
Socio-cultural aspects
of TB
Although patients reported felt
and enacted stigma, they
reported good adherence to
treatment
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Table 2 (Continued )
No. Country Authors Methods Participants and other
details
Conceptual framework Selected ﬁndings in relation to
stigma
14 UK Craig and Zumla,
2015 [64]
Qualitative interview
study
7/17 participants were
African migrants; the
majority were homeless
and had complex medical
and social needs,
including drug and
alcohol use or
immigration issues
Social context of
adherence; critical
health, psychology/
SDH
Reported on an example of felt
stigma
TB used as an excuse to shun and
evict a person because of dislike
Others reported social
distancing, sympathy,
indifference and acceptance
15 UK Brewin et al., 2006
[67]
Qualitative interview
study
53 adult immigrants None reported Stigma not mentioned
Acceptability of screening high
in migrant communities, seen as
a socially responsible activity
The view of screening unfairly
targeted at migrants not
supported
16 Norway Sagbakken et al.,
2010 [74]
Qualitative interview
study
22 patients from Somalia
and Ethiopia; the duration
of stay in Norway varied
from 6months to 16 years
None reported Stigma not mentioned, but there
was a suggestion that perceived
negative attitudes of health care
staff toward migrants could
result in delays in health care
seeking
17 UK Gerrish et al., 2012
[59]
A focused ethnography,
interviews, and focus
group
48 individual interviews;
8 focus groups, involving
56 people; community
leaders from Somali
organizations; members
of the wider Somali
community and patients
whowere receiving or had
recently completed TB
treatment
Socio-cultural
meanings
Authors developed model of
stigma based on beliefs,
attitudes, experiences of
anticipated or actual stigma
The concepts of felt and enacted
stigma were also drawn upon.
18 USA Marks et al., 2008
[70]
National health interview
survey
190 350 unweighted and
209 560 379 weighted
respondents; civilian,
non-institutionalized
household residents from
2000 to 2005
K-A-B Poor knowledge of TB
transmission and curability in
general population
Experience of shame more likely
in marginalized groups
19 UK Seedat et al., 2014
[68]
Qualitative interview
study
20 interviews with
community leaders
representing new
migrants groups
None reported Screening acceptable
Barriers include disease-related
stigma in communities and
perceptions that services are non
migrant friendly – not accessible
to migrants
20 Sweden Kulane et al., 2010
[61]
Qualitative research 5 focus groups with
34 adult women and men
from the Somali
community living in
Stockholm
None reported Use of interpreters a concern if
they came from the same
community as the patient.
Contact tracing associated with a
fear of deportation
21 UK Craig et al., 2014
[65]
Qualitative interview
study
7/17 were African
migrants; the majority
were homeless and had
complex medical and
social needs, including
drug or alcohol use or
immigration issues
Critical health
psychology/SDH
Fear of drug withdrawal in PWID
– major barrier to health seeking
Stigma not reported as people
did not associate symptomswith
TB
22 Canada Møller, 2010 [69] Qualitative ethnographic
research, interviews/
observations
29 Inuit; 7 interviews of
health care professionals
None reported Participants discussed illness
experiences in the context of
oppression, prejudice, and
racism
Examples of discrimination
within and outside the health
care system impacted on the
experiences of TB
K-A-B, knowledge, attitudes, beliefs; TB, tuberculosis; HCP, health care professionals; LTBI, latent TB infection; SDH, social determinants of health; EMIC, explanatory model
interview catalog; PWID, people who inject drugs.
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attitudes, and beliefs (K-A-B) about TB, or studies on the socio-
cultural understandings or experiences of affected communities.
This is not surprising given that qualitative research aims to allow
such themes to emerge from the data. Other studies included
questions on stigma in relation to the broader aims of capturing
knowledge and beliefs about TB or infectious diseases more
generally.Two studies focused on a range of infectious diseases in
addition to TB, including a study that aimed to raise awareness of
infectious diseases in refugee communities52 and an interview
study with community leaders exploring the acceptability of
screening for infectious diseases in recent migrants.67 In the latter
study, although screening was reported to be acceptable, ‘disease-
related stigma’ was found to be a barrier. The study by Brewin et al.
also focused on the acceptability of TB screening in migrant
Table 3
Range of questions/scales used in the studies to measure stigma
Colson et al., 2014 [54]
Stigma
Do people who know that you have TB treat you differently?
Are you concerned that others may ﬁnd out that you have TB?
When you went for TB treatment, were you afraid you might be sent back
to the country you came from?
Group norms
Have you told people close to you that you have TB?
Marks et al., 2008 [70]
If you or a member of your family were diagnosed with TB, would you feel
ashamed or embarrassed?
Sheik and MacIntyre, 2009 [53]
Would not be ashamed if family member had TB
Sins can cause TB
West et al., 2008 [58]
What would you think about a person with TB?
Coreil et al., 2010 [56]
Internal perceptions and emotions
e.g., Would Jean think less of himself because he has TB?
Disclosure
e.g., Do you think Jean would discuss this problem with family members/
close friends/neighbours?
External perceptions
e.g., Would people assume he [Jean] has HIV?
External actions
e.g., Do you think people might avoid Jean because of his actions?
Courtesy stigma
e.g., Would contact with Jean have bad effects on others around him even
after he is treated?
Haitian identity
e.g., Is it more embarrassing for Jean to have TB because he is Haitian than
it would be for other people in Florida?
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ﬁndings.66 Rather, screening was reported as a socially responsible
activity with a high degree of acceptability in migrant communi-
ties. Craig and colleagues suggested that stigma was not reported
as a barrier to accessing health care, as patients with complex
health and social needs generally did not attribute their symptoms
to TB, rather they normalized their symptoms in the context of
their everyday lives.64 Only one study focused on LTBI in Canada;
the authors argued for greater awareness of LTBI and measures to
reduce LTBI-related stigma in Chinese migrant communities.61
3.5. How was stigma measured?
Where studies set out to explore TB-related stigma, the majority
used structured questions to determine attitudes and beliefs about
TB and hence stigma (see Table 3). Colson et al., in a cross-sectional
study ascertaining the attitudes and beliefs of people diagnosed
with TB and born outside the USA/Canada, used structured
questionnaires administered in face-to-face interviews.53 Of the
14 attitudinal items, three questions were designed to measure
stigma, including differential treatment by others, concern about
others knowing a person’s TB status, being found out, and concerns
about deportation. A further question on disclosure was included
under group norms, rather than stigma, but could be used as a proxy
for stigma. West et al. used a standardized list of questions to guide
focus group discussions and asked participants what they thought
about people with TB.57 Sheik and MacIntyre piloted a question-
naire to evaluate a change in attitudes, knowledge, and health
beliefs before and after an educational intervention in a structured
questionnaire administered face-to-face and asked the participants
if they would be ashamed if a family member had TB or whether TB
was caused by sin.52 Marks and colleagues, in a national health
survey in the USA that included seven questions on TB, one ofwhich
addressed stigma, asked whether the respondent, or family
members, would feel shame and embarrassment if diagnosed with
TB.69 In the study by Coreil et al., the researchers adapted a semi-
structured instrument to include a stigma scale with 22 core items
for the Haitian sample and 24 for the Florida sample.55 The scale
explored internal perceptions and emotions (2 items), disclosure
(6 items), external perceptions (4 items), external actions (6 items),
and courtesy stigma (3 items), as well as two items that related
speciﬁcally to Haitian identity as migrants in Florida, and thereby
attempted to capture the intersection of TB stigma with migrant
identity. The internal consistency of the scale was reported to be
good (Cronbach’s alpha >0.80).
3.6. Conceptual frameworks
As there were few studies that aimed to research stigma, the
range of conceptual models theorizing stigma was limited. The
study by Coreil et al. drew on perceived and anticipated stigma;55
Nnoaham et al. drew on felt and enacted stigma.62 Coreil focused
on the social production of perceived and anticipated stigma
informed by the political and economic context, institutional
policies, and health service delivery structures. Disease-related
stigma and community stigma were also reported.67
Two studies drew on the concepts of felt and enacted stigma to
illustrate their ﬁndings.58,63 Gerrish et al. devised a model on the
meaning and consequences of TB, including ways in which
historical contexts, cultural norms, and individual experiences
inﬂuence ideas about the causes, transmission, and treatment of
TB, which then inﬂuenced attitudes and translated into antici-
pated stigma (felt stigma– fear of discrimination, a sense of shame
and lack of self-worth) or enacted stigma (experience of
discrimination, social isolation, and social exclusion leading to
feelings of low self-esteem and risk of depression, with theresulting coping strategies of withdrawal, concealment, or open/
partial disclosure).58
Excluding the three research studies that analysed textual print
media,70,71,81 seven of 19 studies adopted a K-A-B approach to TB/
infectious diseases (see Table 2), including one study that was
explicitly premised on the health belief model (HBM) as a lens to
understand the views of participants.65 Four studies drew on the
socio-cultural meanings participants ascribed to TB,56,58,59 three
studies explicitly adopted a structural/social determinants ap-
proach,55,63,64 and ﬁve studies did not report the use of a
conceptual framework.60,66-68,73 Although one of these related
the experiences of indigenous people to a history of colonialism.68
The predominance of the K-A-B studies is not surprising given
the dominance of social cognition models, in the literature on
health-seeking practices. The HBM was initially developed to
understand the reasons for the failure of a free, preventative TB
screening programme in the USA in the 1950s.72 Social cognition
models posit a (linear and possibly incremental) relationship
between knowledge, beliefs, and access to health care, but have
been criticized for their rational actor approach, which overstates
individual agency.38 The role of structures, including the wider
socio-economic and programmatic barriers, are therefore often
under-theorized within these models. Generally K-A-B studies
recommended increasing awareness of disease through an educa-
tion-through-information approach levelled at the individual or
community. Additionally some K-A-B studies also acknowledged
programmatic barriers, for example, the cost of treatment.61
3.7. Stigma and programmatic barriers
A number of studies brought into relief the programmatic
barriers to health-seeking practices and illness management. Craig
and Zumla, for example, reported on the zero tolerance policies of a
hospital on the use of drugs and alcohol as a barrier to accessing
care.63 The perception that methadone was under-prescribed for
those patients who used drugs, and the subsequent fear of
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TB and infectious disease screening, including HIV, reported high
levels of acceptability amongst migrant communities,64 but choice
of place of screening was considered crucial and some screening
facilities were not viewed as accessible or migrant-friendly.67 Fear
of deportation as a result of contact tracing was also reported in a
Swedish study involving the Somali community.60 One study in
Norway suggested that delays in seeking health care was
attributed to the negative attitudes of staff. Contact tracing was
associated with the threat of deportation, and the use of
interpreterswas of concern if they came from the same community
as the patients.73 These studies suggest that stigma per se may not
be a barrier to accessing health care, but rather policies that can be
discriminatory and service delivery models that are not patient-
centred and that may additionally reinforce stigma. Interventions
at the programmatic level would be needed in these examples.
3.8. Stigma and structural determinants
There were studies that analysed the wider structural causes of
stigma; for example, the study by Coreil et al. demonstrated the
intersection of stigma, discrimination, and identity as a migrant in
a sample of Haitians in Florida compared with non-migrant
Haitians in Haiti.55 The study highlighted how TB policies, such as
detention, intersected with the marginalized status of Haitians
living in the USA and their migrant identity in ways that were
speciﬁc to the USA context compared with non-migrant Haitians
living in Haiti. In one study of the Inuit community, participants
discussed their experiences of TB in the context of colonialism,
oppression, prejudice, and racism.68 They recounted examples of
inhumane treatment historically in relation to TB control polices.
Examples of discrimination within and outside of the health care
sector therefore impacted on their experiences of TB. The author
concluded that decolonizing measures were necessary to address
the high incidence of TB.
The three studieswith a focus on textual analyses of printmedia
and newspaper articles used discourse theory to explore repre-
sentations of TB and migrants in Australia,70 Canada,81 and New
Zealand.71 The authors argued that media reporting served to
stigmatize migrant communities by racializing TB and construct-
ing migrants as the health threat; the focus on migrant screening
and surveillance also served to reinforce stigma by suggesting the
locus of the problem was migrants rather than the social
determinants of disease.
Marks et al. identiﬁed poor knowledge of TB transmission and
curability among a representative sample of the general popula-
tion in the USA, suggesting a lack of awareness was not only an
issue for those communities most affected.69 A small percentage
(2%) reported feeling ashamed or embarrassed if they had a family
member with TB, and this relationship increased if the respondent
was homeless or a prisoner (2.2-times as likely), or born outside
the USA (1.5-times as likely). Similar patterns were found with
ethnic status (black) and education (low), reﬂecting the intersec-
tion between stigma and social positioning, particularly amongst
marginalized groups, but in general the intersection of the SDH
was under-theorized. These complex intersections present chal-
lenges for stigma reduction interventions in terms of how they can
be tailored to speciﬁc groups and contexts.
4. Discussion
Stigma research in low incidence countries is mainly conducted
in migrant populations because these groups are over-represented
in the TB statistics and comprise the majority of communities
affected by TB. A number of studies included interviews with
community leaders who represented the views of those commu-nities. Although valued as an important source of expertise within
those studies, this does raise issues about who represents the
voices of communities and which sectors of the community are
included or excluded in these accounts. Few studies in this review
addressed stigma as a substantive topic, rather stigma emerged as
a theme within studies that aimed to explore knowledge, beliefs,
and health-seeking practices more generally. This contrasts with
research in the HIV ﬁeld,74 where the evidence base is more
extensive.
There was only one study that reported on LTBI and LTBI-
related stigma, although it was unclear whether LTBI stigma was
qualitatively different to TB stigma.61 No studies focused on the
relationship between HIV and TB stigma and no studies focused on
stigma in relation to drug-resistant TB. This may be because the
number of people who experience HIV–TB co-infection or drug-
resistant disease is relatively small in low incidence countries
compared to high disease burden contexts. The difﬁculty of
accessing the views of these groups and indeed the impact of
stigma and willingness to participate in research may also be
reasons. Research in high disease burden countries suggests
patients with multidrug-resistant and extensively drug-resistant
TBmay experience particular forms of stigmatization on account of
their incurable and contagious state.75 No research focused on TB-
related stigma in health care workers and no studies attended to
gender as a social determinant.
Both quantitative and qualitative research was used and only
one study reported on the use of a validated stigma scale to
measure stigma.55 The dearth of intervention studies is worthy of
comment. Courtwright and Turner, in their systematic review of
the global TB literature, similarly concluded that interventions to
reduce TB stigma and analyses of how they impact on diagnostic
delay and treatment adherence are few.28 Yet no studies have
investigated whether and how TB stigma reduction impacts on TB
morbidity and mortality.28,42,45 While some interventions, such as
TB clubs,45 have been reported to decrease stigma and improve
adherence, other interventions involving an educational compo-
nent have not.28
Moreover intervention studies would clearly beneﬁt from a
stronger theoretical underpinning in relation to the social
determinants. K-A-B studies, which assume improving knowledge
will result in health-seeking, premised on an information-through-
education model, fail to take into account the structural barriers
that impact on health-seeking practices and ways in which social
positioning intersect with racism and discrimination for example.
Avoidance of health care may be less to do with stigma than fear of
discrimination based on other factors. The difﬁculty for any
intervention study will be to identify, theorize, and take action on
those very structural factors. Lessons may be learned from the HIV
ﬁeld, where socio-ecological models have been applied routinely
to interventions to tackle the multiple drivers of stigma in people
with HIV.42,76,77 Attention and action on HIV stigma have also
stemmed from the creation of a distinct, indeed exceptional, HIV
community as a result of the more acute levels of discrimination
experienced by those affected in the early stages of the global
epidemic. The very forces that suppressed the rights of people with
HIV led to mass movements of global resistance, world over, to
quell systematic actions on the parts of individuals, systems, and
governments, that could compound their stigmatization.78,79 This
is in sharp contrast to responses for TB, where collective efforts to
empower communities most affected by TB have struggled to
gather commensurate momentum.
In line with other research, TB control programmes and
practices were reported to (inadvertently) contribute to, or cause,
stigma. In one systematic review of qualitative research on TB in
migrant populations, the authors reported that TB-related stigma
has been prominent because of the assumed impact on TB
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programmes’’ (page 9).80 Authors have cautioned about theway TB
is represented in research or the popular press as a disease of
migrants or ‘‘foreign born and hence the outsiders’’ and a ‘‘non-
native threat’’81 (page 129). This raises ethical issues about theway
communities are represented in research and in TB control
programmes.82–84
Few studies embraced a SDH framework to render legible the
experiences of participants and there was a tendency to homoge-
nize experiences of a diverse range of migrants, rather than
theorize difference according to social positioning (e.g., gender).
Despite a global consensus on the relevance of the social
determinants of TB and the relevance and recognition of a SDH
framework across many research disciplines, including the global
policy world, they are often not effectively translated into policy
and action. This is partly because SDH, such as stigma, tend to be
conceptualized as mere individual barriers to health interventions
rather than structural factors (as evidenced by the number of
studies conceptualizing TB stigma within an individualistic K-A-B
framework), and partly because of the limited understanding of the
exact relationship between SDH and health (as evidenced by the
overall limited number of comprehensive in-depth case studies of
stigma). Effective policy and action, taking into account stigma as a
SDH, thus requires extensive and in-depth case studies to allow a
careful and comprehensive understanding of the different
elements of stigma and how they interact at local, national, and
global levels.47
4.1. Questions and challenges for future research
Given TB predominantly affects migrant communities or
newcomers in low incidence countries, further research into
effective strategies for reducing TB stigma in migrant and other
populations within a SDH framework is warranted. Although
lessonsmay be learned from evidence based on ﬁndings in low and
middle income countries, these will need to be translated and
adapted to local country contexts. More research is needed to
determine differences in experience, both within and between
migrant communities and in relation to LTBI and active disease, but
also how people’s experiences are inﬂuenced by the wider social
and structural determinants.
A structural approach to the causes of stigma inevitably raises
more complex theorizations of the intersections between stigma,
other stigmatizing illnesses (HIV, hepatitis), stigmatized identities
(sex worker, drug user), and social positioning (e.g., migrant,
gender). There are gaps in this regard in low incidence countries.
The difﬁculty of measuring the effectiveness of TB stigma
reduction strategies that take into account the complex ways in
which these social determinants intersect should not be under-
estimated,85 particularly in marginalized communities. Chang and
Cataldo argue that cultural variations need to be factored into
interventions aimed at reducing stigma and improving treatment
adherence, which, given the diversity of communities affected,
presents its own challenges.46 Møller cautions that culturally
appropriate health care may be difﬁcult to deliver to indigenous
communities, not least because of the colonial models of health
professional education (page 42).68 Indeed we might ask how
different identities and social positioning interact with the very
interventions to tackle stigma and the implications for engage-
ment with such interventions.
The need to translate measures and tools into the various
community languages, given migrant populations are not homo-
geneous, will also present cost and logistical challenges.64 For
example in London, UK, approximately 22% of people do not speak
English as their ﬁrst language, and in some London boroughs, over
100 different languages are spoken, a pattern common in manymajor cities, suggesting a role for bilingual researchers. Process
evaluations and sophisticated qualitative methods, including
ethnographic approaches and case studies, will be needed to
inform the development of future interventions and to measure
outcomes, in addition to providing rich contextual detail to better
understand how complex interventions work.86 Finally the major
challenge for TB programmes and researchers will be how to
research and report on the experiences of vulnerable communities
in ways that do not reinforce stigma. This is particularly difﬁcult
when interventions, and hence research, are targeted at affected
communities in low incidence countries rather than the general
population.
4.2. Conclusions
There is scant research into the assessment of TB stigma in TB in
low incidence settings. As stated by Macq et al. ‘‘It is striking to see
that stigma is at the center of global strategies to ﬁght AIDS and it is
so little present in the international priorities of TB control’’ (page
351).74
Priority action 7 of the WHO and ERS framework for the
elimination of TB in low incidence countries recognizes the need to
invest in research and new tools.5 There is some evidence to
suggest that in addition to TB, TB control measures may be
experienced as stigmatizing or discriminatory by different
communities in low burden settings. There is much less research
on how the social determinants intersect with stigma and
interventions to reduce stigma, including what such interventions
should look like and how reductions in stigma can be measured.
The framework may provide a driver for gaps in research on
stigma. Finally approaching stigma as a problem requiring a
technical ﬁx by the health sector, without addressing the inequities
that place communities at risk of disease and poor health outcomes
will have little impact without accompanying global political
solutions.87
4.3. Limitations
It is possible that some research was missed, as not all articles
were read in full if stigma was not mentioned in the abstract or if
the abstract did not indicate the study was relevant for full article
review. Givenmuch research focused on knowledge, attitudes, and
beliefs, in which stigma emerges as a theme rather than an extant
focus, this only adds to the contention that, unlike HIV stigma, TB
stigma is rarely researched as a topic in its own right in low burden
countries, despite being an important SDH. This may reﬂect the
dominance of biomedical research. Some studies were not
included because they fell outside the period of study for the
review (i.e., before 2006). However given that the populations
affected by TB, TB as a disease, and stigma are dynamic, social
phenomena with manifestations contingent upon time, place,
space, social positioning, and geo-political factors, experiences and
solutions derived from research more than 10 years ago may need
to be reappraised in the contemporary situation, including their
relevance to low burden settings. The research studies were not
appraised for quality; some have argued that mapping research
studies without addressing quality may be of limited value.48
However the aimwas to map the nature of research into TB stigma
(including stigma reduction interventions) in low incidence
countries and the conceptual frameworks adopted, to provide a
better understanding of how stigma operates and intersects with
other social statuses or positioning. Few studies set out to address
these aims and therefore achieved this ‘gold standard’ in this
review.
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Example of search terms used in relation to stigma in CINHAL
(‘‘Stigma’’) OR (MH ‘‘Stereotyping’’) OR (MH ‘‘Social Attitudes’’) OR (MH ‘‘Social
Norms’’) OR (MH ‘‘Social Behavior’’) OR (MH ‘‘Social Identity’’) OR (MH ‘‘Social
Conformity’’) OR (MH ‘‘Social Inclusion’’) OR (MH ‘‘Social Isolation’’) OR
(MH ‘‘Social Alienation’’) OR (MH ‘‘Social Participation’’) OR (MH
‘‘Social Values’’) OR (MH ‘‘Vulnerability’’)
AB discriminat* OR AB prejudice* OR AB ‘‘social determinants’’ N3 health OR
AB ‘‘social* exclus*’’ OR AB marginali#* OR AB soci* N3 reject* OR AB scapegoat*
AB stigma OR AB stereotyp* OR AB ‘‘social attitudes’’ OR AB ‘‘social norms’’ OR
AB ‘‘social behavio#r’’ OR AB ‘‘social identit*’’ OR AB ‘‘social conformity’’
OR AB ‘‘social* inclusi*’’ OR AB ‘‘social* isolat*’’ OR AB ‘‘social alienat*’’
OR AB ‘‘social participation’’ OR AB ‘‘social values’’
(MH ‘‘Social Determinants of Health’’) OR (MH ‘‘Health Status Disparities’’)
(MH ‘‘Prejudice’’) OR (MH ‘‘Scapegoating’’) OR (MH ‘‘Social Conformity’’) OR
(MH ‘‘Social Desirability’’)
(MH ‘‘Social Norms’’) OR (MH ‘‘Social Isolation’’) OR (MH ‘‘Social Alienation’’)
(MH ‘‘Social Stigma’’) OR (MH ‘‘Stereotyping’’) OR (MH ‘‘Social Marginalization’’)
OR (MH ‘‘Social Isolation’’) OR (MH ‘‘Social Discrimination’’)
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